Core Nursing Explanation
Key Concept Analysis: This question assesses the priority nursing intervention for a late preterm infant (35 weeks) presenting with respiratory distress. The core theme is recognizing the likely underlying cause—
Respiratory Distress Syndrome (RDS)—and understanding the definitive, life-saving treatment. RDS is primarily caused by a deficiency of
pulmonary surfactant, a substance produced by type II alveolar cells that reduces surface tension in the lungs, preventing alveolar collapse at the end of expiration. Late preterm infants (34-36 weeks) are at significant risk for surfactant deficiency as their lungs are still maturing.
Answer Rationale:
Key Point! The highest priority intervention is to
prepare for surfactant replacement therapy administration. This directly addresses the primary pathophysiological problem of surfactant deficiency. Administering exogenous surfactant improves lung compliance, reduces the work of breathing, and decreases the need for high levels of oxygen and mechanical ventilation. It is a critical, time-sensitive intervention to prevent further respiratory deterioration and complications like
bronchopulmonary dysplasia (BPD).
Distractor Analysis:
Watch out for confusion! Option ① (Administer prophylactic antibiotics) is incorrect because it addresses a potential complication (infection) rather than the immediate, life-threatening cause of the distress. While sepsis can mimic RDS, the scenario specifies "mild respiratory distress" in a late preterm infant, making RDS the most probable primary diagnosis. Antibiotics are not a treatment for surfactant deficiency.
Option ② (Position the infant in prone position) is a supportive measure. While the prone position can improve oxygenation by optimizing ventilation-perfusion matching and reducing the work of breathing, it is a
non-invasive, supportive intervention that does not correct the underlying surfactant deficiency. It would be implemented, but it is not the definitive, highest-priority treatment.
Option ④ (Initiate phototherapy) is incorrect because it addresses a common comorbidity in preterm infants—
hyperbilirubinemia—but is unrelated to the primary problem of respiratory distress. Jaundice and respiratory distress are managed concurrently but independently; phototherapy is not an intervention for improving respiratory status.
Related Concepts: The nursing process guides us to prioritize interventions that address the most immediate threat to life (Airway, Breathing, Circulation - ABCs). In this case, surfactant therapy directly supports "Breathing." Understanding the
pathophysiology of RDS is essential for predicting clinical signs (tachypnea, grunting, retractions, nasal flaring) and anticipating the necessary medical and nursing interventions.
Concept Summary
| Concept | Key Takeaway |
| Respiratory Distress Syndrome (RDS) | Surfactant deficiency leads to alveolar collapse, poor lung compliance, and respiratory distress in preterm infants. |
| Surfactant Replacement Therapy | Definitive, high-priority treatment for RDS. Administered via endotracheal tube, often requiring careful positioning and monitoring. |
| Late Preterm Infant (34-36 weeks) | High risk for RDS, temperature instability, feeding difficulties, and hyperbilirubinemia. |
| Nursing Priority (ABCs) | Airway and Breathing are top priorities. Interventions that directly support these systems take precedence. |
Side-by-Side Comparison!
| Intervention | Purpose / Indication | Priority in RDS |
| Surfactant Therapy | Replace deficient pulmonary surfactant to improve lung compliance. | HIGHEST - Corrects the root cause. |
| Prone Positioning | Supportive care to improve oxygenation and reduce work of breathing. | Supportive - Helps manage symptoms. |
| Prophylactic Antibiotics | Prevent or treat bacterial infection (e.g., sepsis, pneumonia). | Secondary - Used if infection is suspected or proven. |
| Phototherapy | Treat hyperbilirubinemia by breaking down bilirubin in the skin. | Concurrent Care - Addresses a common comorbidity, not the respiratory issue. |
Anatomy, Physiology & Pharmacology Points
- Physiology: Surfactant is produced by type II pneumocytes. Production significantly increases after about 35 weeks gestation. A deficiency increases alveolar surface tension, leading to atelectasis (collapse), decreased lung compliance, ventilation-perfusion mismatch, and hypoxemia.
- Pharmacology: Exogenous surfactants (e.g., beractant, poractant alfa) are derived from animal lungs. Administration is an intratracheal instillation. Nursing responsibilities include ensuring correct dosing, preparing for potential airway obstruction during administration, and monitoring for rapid improvements in oxygenation and compliance.
Memory Tips
- Mnemonic for RDS Signs: "Grunting, Retractions, Apnea (or flaring), Cyanosis, Tachypnea" → GRACT.
- Think: "No SURFactant, can't catch a breath wave." The priority is to give the SURF (surfactant).
- Rule of 35: Infants born before ~35 weeks are at high risk for surfactant deficiency. The question's "35-week" infant is right on the cusp.
High-Frequency NCLEX Topics
NCLEX frequently tests priority-setting for neonatal emergencies. RDS and its management are core topics. Remember:
Treat the cause, not just the symptoms. In neonatal respiratory distress, always consider surfactant deficiency first for preterm infants, and be ready to assist with or prepare for its administration as a top-priority action.
Watch Out for Question Variations!
- Symptom Identification: "The nurse assesses a 33-week preterm infant. Which finding is most suggestive of RDS?" (Look for grunting, retractions).
- Post-Surfactant Care: "Following surfactant administration, which action is most important?" (Monitor for acute airway obstruction and assess oxygenation/ventilation).
- Prevention Focus: "The nurse is teaching a client at risk for preterm labor. Which intervention is most effective in preventing RDS?" (Administration of antenatal corticosteroids to the mother to accelerate fetal lung maturity).